Lord, Abbett & Co’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Lord, Abbett & Co's UTHR Position: Q3 2026 in Review
Lord, Abbett & Co reduced its United Therapeutics (UTHR) stake by 7.6% in Q3 2026, selling an estimated $9.6M and leaving 225,799 shares worth $122M. The position accounts for 0.37% of the portfolio, ranked #69.
Lord, Abbett & Co first reported a position in UTHR in Q2 2024 and has held it in 10 quarters since. The position peaked at $148M in Q1 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Lord, Abbett & Co held 225,799 shares of United Therapeutics worth $122M as of Q3 2026.
- Lord, Abbett & Co sold 18,524 United Therapeutics shares in Q3 2026, an estimated $9.6M.
- United Therapeutics made up 0.37% of Lord, Abbett & Co's portfolio in Q3 2026, its #69 holding.
- Lord, Abbett & Co first reported a position in United Therapeutics in Q2 2024 and has held it in 10 quarters since.
- Lord, Abbett & Co's United Therapeutics position peaked at $148M in Q1 2026.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.